v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Common Stock
Additional Paid in capital
Additional Paid in capital
Series B Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2022     82,653,781        
Beginning balances at Dec. 31, 2022 $ (132,711)   $ 9 $ 513,614   $ 6 $ (646,340)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation 10,123     10,123      
Exercise of stock options (in shares)     250,000        
Exercise of stock options 335     335      
Release of restricted stock units (in shares)     1,606,791        
Cancellation of shares used to settle payroll tax withholding (in shares)     (303,655)        
Cancellation of shares used to settle payroll tax withholding (587)     (587)      
Issuance of common stock (in shares)     72,171,861        
Issuance of common stock 182,810   $ 7 182,803      
Accretion of Preferred Stock 0            
Foreign currency translation adjustment (3)         (3)  
Change in fair value of debt - credit risk 0            
Net income (188,298)           (188,298)
Ending balances (in shares) at Sep. 30, 2023     156,378,778        
Ending balances at Sep. 30, 2023 (128,331)   $ 16 706,288   3 (834,638)
Beginning balances (in shares) at Jun. 30, 2023     127,309,960        
Beginning balances at Jun. 30, 2023 (229,541)   $ 14 620,006   9 (849,570)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation 4,456     4,456      
Exercise of stock options (in shares)     50,000        
Exercise of stock options 67     67      
Release of restricted stock units (in shares)     93,458        
Cancellation of shares used to settle payroll tax withholding (in shares)     (13,584)        
Cancellation of shares used to settle payroll tax withholding (136)     (136)      
Issuance of common stock (in shares)     28,938,944        
Issuance of common stock 81,897   $ 2 81,895      
Foreign currency translation adjustment (6)         (6)  
Change in fair value of debt - credit risk 0            
Net income 14,932           14,932
Ending balances (in shares) at Sep. 30, 2023     156,378,778        
Ending balances at Sep. 30, 2023 $ (128,331)   $ 16 706,288   3 (834,638)
Beginning balances (in shares) at Dec. 31, 2023 199,133,827   199,133,827        
Beginning balances at Dec. 31, 2023 $ (110,800)   $ 21 765,018   7 (875,846)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation 10,940     10,940      
Release of restricted stock units (in shares)     1,941,965        
Exercise of warrants (in shares)     289,654        
Exercise of warrants 463     463      
Cancellation of shares used to settle payroll tax withholding (in shares)     (714,565)        
Cancellation of shares used to settle payroll tax withholding (1,122)     (1,122)      
Issuance of common stock (in shares)     16,627,523        
Issuance of common stock 14,089   $ 2 14,087      
Accretion of Preferred Stock (64,938) $ (64,938)     $ (64,938)    
Foreign currency translation adjustment (1)         (1)  
Change in fair value of debt - credit risk (4,642)         (4,642)  
Net income $ (417,746)           (417,746)
Ending balances (in shares) at Sep. 30, 2024 217,278,404   217,278,404        
Ending balances at Sep. 30, 2024 $ (573,756)   $ 23 724,449   (4,636) (1,293,592)
Beginning balances (in shares) at Jun. 30, 2024     216,491,215        
Beginning balances at Jun. 30, 2024 (190,819)   $ 23 759,881   3 (950,726)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation 6,142     6,142      
Release of restricted stock units (in shares)     913,774        
Exercise of warrants (in shares)     289,654        
Exercise of warrants 463     463      
Cancellation of shares used to settle payroll tax withholding (in shares)     (416,239)        
Cancellation of shares used to settle payroll tax withholding (771)     (771)      
Accretion of Preferred Stock   $ (41,267)     $ (41,267)    
Foreign currency translation adjustment 3         3  
Change in fair value of debt - credit risk (4,642)         (4,642)  
Net income $ (342,866)           (342,866)
Ending balances (in shares) at Sep. 30, 2024 217,278,404   217,278,404        
Ending balances at Sep. 30, 2024 $ (573,756)   $ 23 $ 724,449   $ (4,636) $ (1,293,592)